Mark’s Substack

Mark’s Substack

Share this post

Mark’s Substack
Mark’s Substack
United Laboratories and Novo Nordisk Ink Deal for GLP-1/GIP/Glucagon Triple Receptor Agonist

United Laboratories and Novo Nordisk Ink Deal…

Mark Terry
Mar 24

Share this post

Mark’s Substack
Mark’s Substack
United Laboratories and Novo Nordisk Ink Deal for GLP-1/GIP/Glucagon Triple Receptor Agonist

Novo Nordisk makes move to expand on GLP-1 combination market

Read →
Comments
User's avatar
© 2025 Mark Terry
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share